THE CYTEL RANGE
A Novel Approach For Hypertension
The Cytel range offers multiple treatment options designed to support individualized management of hypertension. By combining Telmisartan with complementary agents in specific strengths, the range allows healthcare professionals to tailor therapy based on patient needs, blood pressure response, and associated cardiovascular risk factors.
WHY CYTEL
Designed for Flexible and Targeted Treatment
Hypertension management often requires different therapeutic approaches over time. The Cytel range includes monotherapy and combination options that help address varying levels of blood pressure control and patient profiles, under medical supervision.
Key considerations behind the range include:
- Flexibility in dosing and combinations
- Support for long-term blood pressure control
- Options suited for different clinical requirements
The Cytel Tablets Range Includes
Multiple Combinations, One Therapeutic Focus
Telmisartan 20 mg
A lower-dose option for patients requiring initial or mild blood pressure control.
Telmisartan 40 mg
A standard dose option commonly used for sustained blood pressure management.
Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg
A combination option that includes a diuretic to support additional blood pressure reduction.
Telmisartan 40 mg + Amlodipine 5 mg
Designed to combine vascular relaxation with renin-angiotensin system control.
Telmisartan 40 mg + Metoprolol Succinate 25 mg
A combination that supports blood pressure control along with heart rate management.
Telmisartan 40 mg + Metoprolol Succinate 50 mg
An option for patients requiring stronger beta-blocker support under clinical guidance.
Telmisartan 40 mg + Chlorthalidone 6.25 mg
A lower-dose diuretic combination aimed at gradual blood pressure reduction.
Telmisartan 40 mg + Chlorthalidone 12.5 mg
A higher diuretic strength for patients needing enhanced volume control.
Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg
A triple-combination option for patients requiring multidimensional blood pressure management.
Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 6.25 mg
A lower-dose triple combination option for patients requiring multi-mechanism blood pressure control with moderated diuretic intensity.
Telmisartan 40 mg + Cilnidipine 10 mg
A dual-mechanism combination designed to address vascular resistance while supporting sustained blood pressure regulation.
Telmisartan 40 mg + Cilnidipine 10 mg + Metoprolol 25 mg
A combination option for patients requiring additional heart rate control alongside comprehensive blood pressure management.
Compliance and Patient Note - The Cytel range is intended to support prescribed treatment plans and should be used only as directed by a qualified healthcare provider.
The Cytel Team
Avinash Pakhurde
Territory Business Manager – Panvel HQ
“In Panvel, we have observed that many hypertension patients struggle not just with diagnosis but with long-term affordability and regular follow-up.
Through Cytel, we focus on ensuring consistent availability of therapy at reasonable cost, so patients do not discontinue treatment midway.
Along with doctors, we actively support awareness discussions on blood pressure control and lifestyle management.
Our objective is simple — make hypertension management accessible, affordable, and sustainable for every patient.”
Jaydeep Kalekar
Business Executive – Dapoli HQ
“In semi-urban regions like Dapoli, patient awareness about metabolic disorders is still developing.
Cytel initiatives have helped us work closely with healthcare professionals to promote regular BP monitoring and early screening.
By ensuring steady supply and cost-effective therapy options, we aim to reduce treatment dropouts.
When patients understand their condition and can afford their medicines, long-term health outcomes improve significantly.”
Siddhesh Karkote
Business Executive – Kudal HQ
“Many patients in Kudal region depend on continuous medication for hypertension and metabolic conditions.
Our focus has been on supporting doctors with reliable therapy options and spreading awareness about the importance of daily compliance.
Through patient education materials and regular engagement, we help reinforce the message that controlling blood pressure today prevents complications tomorrow.
Cytel stands for continuity of care, not just treatment.”
Jigar Bhonkar
Area Business Manager – Mumbai HQ
“In a fast-paced city like Mumbai, lifestyle disorders are rising rapidly.
Through Cytel awareness initiatives, we aim to support doctors in educating patients about early detection, regular monitoring, and long-term adherence.
Accessibility, affordability, and patient confidence are key pillars of our approach.
We believe healthcare is meaningful only when it reaches patients consistently and responsibly.”
